These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2001577)

  • 1. Clinical trials. Access and reimbursement.
    Farrar WB
    Cancer; 1991 Mar; 67(6 Suppl):1779-82. PubMed ID: 2001577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs studies show clinical trials, standard therapy may be equal.
    Reynolds T
    J Natl Cancer Inst; 2000 Jul; 92(14):1116-8. PubMed ID: 10904079
    [No Abstract]   [Full Text] [Related]  

  • 3. Reimbursement issues facing patients, providers, and payers.
    Antman K
    Cancer; 1993 Nov; 72(9 Suppl):2842-5. PubMed ID: 8402516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental treatment costs in national cancer institute-sponsored clinical trials.
    Goldman DP; Berry SH; McCabe MS; Kilgore ML; Potosky AL; Schoenbaum ML; Schonlau M; Weeks JC; Kaplan R; Escarce JJ
    JAMA; 2003 Jun; 289(22):2970-7. PubMed ID: 12799405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reimbursement of biotherapy: present status, future directions--perspectives of the hospital-based oncology nurse.
    McCabe MS
    Semin Oncol Nurs; 1992 Nov; 8(4 Suppl 1):3-7. PubMed ID: 1462056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient care cancer clinical trials at the National Cancer Institute: a resource for payers and providers.
    Pearson D
    Manag Care Q; 2002; 10(1):33-7. PubMed ID: 15988953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCI seeks more patients for trials.
    Zoler ML
    Med World News; 1988 Jun; 29(12):23. PubMed ID: 10287972
    [No Abstract]   [Full Text] [Related]  

  • 8. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
    Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
    J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who should subsidize NCI clinical trials?
    Ault A
    Nat Med; 1998 Sep; 4(9):992. PubMed ID: 9734381
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials: are they a good buy?
    Bennett CL; Adams JR; Knox KS; Kelahan AM; Silver SM; Bailes JS
    J Clin Oncol; 2001 Dec; 19(23):4330-9. PubMed ID: 11731516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness and reimbursement in patient care.
    Antman KH; Aledort LM; Yarbro J; Wilensky G; Wojcik S; Monaco GP; Windham S
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):32-45. PubMed ID: 2508228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of clinical trial protocols on patient care systems at the University of Texas M.D. Anderson Cancer Center.
    Huber SL
    Cancer; 1993 Nov; 72(9 Suppl):2824-7. PubMed ID: 8402512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A progress report on reimbursement of biotherapy: prospects for the 1990s.
    Yasko JM
    Oncol Nurs Forum; 1989; 16(6 Suppl):42-7. PubMed ID: 2687813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reimbursement issues in clinical oncology.
    Vogelzang NJ; Chabner BA; Periman P; Ohrt DK; McCann BC; Burns JM; Bayer R
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):34-43. PubMed ID: 3061015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to clinical trial enrollment: are state mandates the solution?
    Hillner BE
    J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Patel JD; Krilov L; Adams S; Aghajanian C; Basch E; Brose MS; Carroll WL; de Lima M; Gilbert MR; Kris MG; Marshall JL; Masters GA; O'Day SJ; Polite B; Schwartz GK; Sharma S; Thompson I; Vogelzang NJ; Roth BJ
    J Clin Oncol; 2014 Jan; 32(2):129-60. PubMed ID: 24327669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstacles to the accrual of patients to clinical trials in the community setting.
    Winn RJ
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):112-7. PubMed ID: 8091236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologist's role critical to clinical trial enrollment.
    Finn R
    J Natl Cancer Inst; 2000 Oct; 92(20):1632-4. PubMed ID: 11036104
    [No Abstract]   [Full Text] [Related]  

  • 19. Summary of a workshop on the role of third-party payers in clinical trials of new agents.
    Chalmers TC; van den Noort S; Lockshin MD; Waksman BH
    N Engl J Med; 1983 Nov; 309(21):1334-6. PubMed ID: 6633594
    [No Abstract]   [Full Text] [Related]  

  • 20. Barriers to clinical trials. Part III: Knowledge and attitudes of health care providers.
    Mansour EG
    Cancer; 1994 Nov; 74(9 Suppl):2672-5. PubMed ID: 7954284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.